Suro Capital [SSSS] vs Ellington Financial [EARN] Detailed Stock Comparison
Suro Capital
NASDAQ
Loading...
Ellington Financial
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Suro Capital wins in 6 metrics, Ellington Financial wins in 11 metrics, with 0 ties. Ellington Financial appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Suro Capital | Ellington Financial | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 4.42 | 20.39 | Suro Capital |
| Price-to-Book Ratio | 0.95 | 0.94 | Ellington Financial |
| Debt-to-Equity Ratio | 33.47 | 226.91 | Suro Capital |
| PEG Ratio | -0.01 | -0.09 | Ellington Financial |
| Profit Margin (TTM) | 2,015.30% | -14.61% | Suro Capital |
| Operating Margin (TTM) | -1,593.16% | 75.59% | Ellington Financial |
| EBITDA Margin (TTM) | N/A | 75.59% | N/A |
| Return on Equity | 29.40% | -2.82% | Suro Capital |
| Return on Assets (TTM) | -2.27% | -0.60% | Ellington Financial |
| Free Cash Flow (TTM) | $2.37M | $9.11M | Ellington Financial |
| Dividend Yield | 2.98% | 14.04% | Ellington Financial |
| 1-Year Return | 124.23% | -16.59% | Suro Capital |
| Price-to-Sales Ratio (TTM) | 74.64 | 5.98 | Ellington Financial |
| Enterprise Value | $231.41M | $715.11M | Ellington Financial |
| EV/Revenue Ratio | 83.11 | 19.92 | Ellington Financial |
| Revenue per Share (TTM) | $0 | $1 | Ellington Financial |
| Earnings per Share (Diluted) | $1.97 | $0.28 | Suro Capital |
| Beta (Stock Volatility) | 1.74 | 1.30 | Ellington Financial |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Suro Capital vs Ellington Financial Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Suro Capital | 0.23% | -0.34% | 4.32% | 15.54% | 46.22% | 48.72% |
| Ellington Financial | -0.35% | -3.40% | -0.87% | 1.25% | -10.83% | -14.84% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Suro Capital | 124.23% | 43.56% | -27.20% | 2.59% | -40.21% | -40.21% |
| Ellington Financial | -16.59% | -27.46% | -49.38% | -56.77% | -70.99% | -70.99% |
Performance & Financial Health Analysis: Suro Capital vs Ellington Financial
| Metric | SSSS | EARN |
|---|---|---|
| Market Information | ||
| Market Cap | $206.39M | $214.46M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 340,060 | 347,110 |
| 90 Day Avg. Volume | 226,710 | 390,077 |
| Last Close | $8.70 | $5.68 |
| 52 Week Range | $3.75 - $9.12 | $4.33 - $7.11 |
| % from 52W High | -4.61% | -20.11% |
| All-Time High | $20.89 (Feb 06, 2012) | $19.85 (May 20, 2013) |
| % from All-Time High | -58.35% | -71.39% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.84% | -0.34% |
| Quarterly Earnings Growth | -10.04% | -1.90% |
| Financial Health | ||
| Profit Margin (TTM) | 20.15% | -0.15% |
| Operating Margin (TTM) | -15.93% | 0.76% |
| Return on Equity (TTM) | 0.29% | -0.03% |
| Debt to Equity (MRQ) | 33.47 | 226.91 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $9.19 | $6.08 |
| Cash per Share (MRQ) | $2.09 | $0.48 |
| Operating Cash Flow (TTM) | $-3,321,491 | $19.53M |
| Levered Free Cash Flow (TTM) | $-7,395,670 | $6.59M |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.98% | 14.04% |
| Last 12-Month Dividend | $0.25 | $0.80 |
Valuation & Enterprise Metrics Analysis: Suro Capital vs Ellington Financial
| Metric | SSSS | EARN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 4.42 | 20.39 |
| Forward P/E | -14.26 | 4.84 |
| PEG Ratio | -0.01 | -0.09 |
| Price to Sales (TTM) | 74.64 | 5.98 |
| Price to Book (MRQ) | 0.95 | 0.94 |
| Market Capitalization | ||
| Market Capitalization | $206.39M | $214.46M |
| Enterprise Value | $231.41M | $715.11M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 83.11 | 19.92 |
| Enterprise to EBITDA | N/A | N/A |
| Risk & Other Metrics | ||
| Beta | 1.74 | 1.30 |
| Book Value per Share (MRQ) | $9.19 | $6.08 |
Financial Statements Comparison: Suro Capital vs Ellington Financial
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SSSS | EARN |
|---|---|---|
| Revenue/Sales | $2.09M | $-5.29M |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | $-806,715 | $-7.88M |
| Income Tax | N/A | $-6,000 |
| Net Income (Profit) | $-806,715 | $-7.87M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SSSS | EARN |
|---|---|---|
| Cash & Equivalents | $16.18M | $17.38M |
| Total Current Assets | N/A | N/A |
| Total Current Liabilities | N/A | N/A |
| Long-Term Debt | $73.25M | N/A |
| Total Shareholders Equity | $156.80M | $228.50M |
| Retained Earnings | $-7.96M | $-171.74M |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SSSS | EARN |
|---|---|---|
| Operating Cash Flow | $-340,868 | $-7.20M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $-3.72M | $9.21M |
| Debt Repayment | $-4.95M | N/A |
| Common Stock Repurchase | N/A | $-979,000 |
Short Interest & Institutional Ownership Analysis
| Metric | SSSS | EARN |
|---|---|---|
| Shares Short | 137,566 | 238,322 |
| Short Ratio | 0.76 | 0.61 |
| Short % of Float | 0.01% | 0.01% |
| Average Daily Volume (10 Day) | 340,060 | 347,110 |
| Average Daily Volume (90 Day) | 226,710 | 390,077 |
| Shares Outstanding | 23.60M | 29.65M |
| Float Shares | 21.91M | 37.05M |
| % Held by Insiders | 0.08% | 0.01% |
| % Held by Institutions | 0.21% | 0.13% |
Dividend Analysis & Yield Comparison: Suro Capital vs Ellington Financial
| Metric | SSSS | EARN |
|---|---|---|
| Last 12-Month Dividend | $0.25 | $0.80 |
| Last 12-Month Dividend Yield | 2.98% | 14.04% |
| 3-Year Avg Annual Dividend | $0.08 | $0.85 |
| 3-Year Avg Dividend Yield | 2.98% | 1.18% |
| 3-Year Total Dividends | $0.25 | $2.56 |
| Ex-Dividend Date | Jul 21, 2025 | Mar 31, 2025 |